Loading…
OPKO Health, Inc. is projected to rise to $1.55 by 2027, a +19% move from its current price of $1.30. OPK is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.27 | $1.30 | $1.33 | +0.02% |
| May 30 | $1.26 | $1.30 | $1.34 | +0.03% |
| May 31 | $1.25 | $1.30 | $1.35 | +0.05% |
| Jun 1 | $1.25 | $1.30 | $1.36 | +0.07% |
| Jun 2 | $1.24 | $1.30 | $1.36 | +0.08% |
| Jun 3 | $1.24 | $1.30 | $1.37 | +0.10% |
| Jun 4 | $1.23 | $1.30 | $1.38 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.23 | $1.30 | $1.38 | +0.12% |
| Week 2 | $1.20 | $1.30 | $1.41 | +0.23% |
| Week 3 | $1.19 | $1.30 | $1.44 | +0.35% |
| Week 4 | $1.17 | $1.31 | $1.46 | +0.47% |
| Week 5 | $1.16 | $1.31 | $1.48 | +0.58% |
| Week 6 | $1.14 | $1.31 | $1.50 | +0.70% |
| Week 7 | $1.13 | $1.31 | $1.52 | +0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OPKO Health, Inc. operates as a healthcare company with activities in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics.
OPKO Health, Inc. (OPK) is a healthcare company trading at $1.27 per share with a market cap of $958.97M, and it is ranked 2564 by market capitalization.
A major floor 20.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 10.3% above — clearing it would confirm fresh momentum.
Key OPK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.27 | Buy | $1.26 | Buy |
| MA 10 | $1.20 | Buy | $1.22 | Buy |
| MA 20 | $1.16 | Buy | $1.19 | Buy |
| MA 50 | $1.17 | Buy | $1.18 | Buy |
| MA 100 | $1.21 | Buy | $1.21 | Buy |
| MA 200 | $1.30 | Sell | $1.27 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.77 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 162.96 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 14.04 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | 0.10 | Buy |
| Ultimate (7,14,28) | 85.60 | Sell |
| Momentum (10) | 0.20 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 1.33 | Sell |
| ADX (14) | 20.44 | Buy |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bullish with RSI14 at 70, and the stock trades around the moving averages SMA50 at $1.16 and SMA200 at $1.30. Support is seen at $1.10 and resistance at $1.28, with a 30-day price range of $1.10 to $1.47.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.10 | $1.30 | $1.76 | 0% | Neutral | |
| $1.26 | $1.55 | $2.01 | +19% | Neutral | |
| $1.34 | $1.68 | $2.24 | +30% | Bullish | |
| $1.40 | $1.79 | $2.44 | +38% | Bullish | |
| $1.61 | $2.09 | $2.90 | +60% | Bullish | |
| $1.81 | $2.38 | $3.37 | +83% | Bullish | |
| $2.03 | $2.71 | $3.88 | +108% | Bullish | |
| $2.32 | $3.13 | $4.56 | +141% | Bullish | |
| $2.31 | $3.15 | $4.64 | +143% | Bullish | |
| $2.35 | $3.24 | $4.83 | +149% | Bullish | |
| $3.54 | $5.12 | $8.02 | +294% | Bullish | |
| $5.99 | $9.37 | $15.83 | +621% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.10 | $1.30 | $1.53 | +0.00% |
| June 2026 | $1.14 | $1.33 | $1.58 | +2.22% |
| July 2026 | $1.12 | $1.32 | $1.59 | -0.68% |
| August 2026 | $1.12 | $1.33 | $1.61 | +0.57% |
| September 2026 | $1.16 | $1.38 | $1.68 | +3.83% |
| October 2026 | $1.18 | $1.41 | $1.73 | +1.99% |
| November 2026 | $1.17 | $1.40 | $1.73 | -0.69% |
| December 2026 | $1.18 | $1.42 | $1.76 | +1.53% |
Click any year to see its month-by-month OPK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OPK price prediction for 2026 points to an average of $1.30 (low $1.10, high $1.76) — a potential gain of 0% on today's $1.30. A consolidation phase looks the most probable path here.
In 2027, OPK is projected to trade between $1.26 and $2.01, averaging $1.55 — a potential gain of +19% from today's $1.30. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
OPKO Health, Inc.'s 2028 outlook centres on $1.68, within a $1.34 to $2.24 range. That is up +9% on the projected 2027 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, OPK could reach as high as $2.44, with a base case around $1.79 and support toward $1.40 — roughly +38% from $1.30. Momentum favours further upside here.
Expect OPK to range from $1.61 to $2.90 through 2030. The $2.09 average target implies a +60% move from current prices. That is up +16% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The OPK price prediction for 2031 points to an average of $2.38 (low $1.81, high $3.37) — a potential gain of +83% on today's $1.30. Momentum favours further upside here.
In 2032, OPK is projected to trade between $2.03 and $3.88, averaging $2.71 — a potential gain of +108% from today's $1.30. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
OPKO Health, Inc.'s 2033 outlook centres on $3.13, within a $2.32 to $4.56 range. That is up +16% on the projected 2032 average. That marks a +141% change versus current levels. Momentum favours further upside here.
By 2034, OPK could reach as high as $4.64, with a base case around $3.15 and support toward $2.31 — roughly +143% from $1.30. Buyers look set to stay in control over this stretch.
Expect OPK to range from $2.35 to $4.83 through 2035. The $3.24 average target implies a +149% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The OPK price prediction for 2040 points to an average of $5.12 (low $3.54, high $8.02) — a potential gain of +294% on today's $1.30. Buyers look set to stay in control over this stretch.
In 2050, OPK is projected to trade between $5.99 and $15.83, averaging $9.37 — a potential gain of +621% from today's $1.30. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OPK today (≈ 769.230769 OPK) could be worth
$7,209.84
+$6,209.84 (+621%) by 2050 · US Dollar
Based on the average projected OPK price of $9.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPKwould be worth at today's price.
$1,000 invested in OPK on May 27, 2025 (≈ 763.358812 OPK) would be worth
$992.37
-$7.63 (-0.8%) today · 0.99× · US Dollar
Based on a OPK entry price of $1.31 vs. today's $1.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.23 | $1,056.91 | +5.7% |
| 1 month ago | $1.2 | $1,083.33 | +8.3% |
| 3 months ago | $1.2 | $1,083.33 | +8.3% |
| 6 months ago | $1.36 | $955.88 | -4.4% |
| 1 year ago | $1.31 | $992.37 | -0.8% |
| All time (5.0y) ago | $3.61 | $360.11 | -64.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPK forecast.
Our base-case forecast reaches $2.60 around 2032.
Implied market cap at $2.60: $1.96B
The multi-year forecast shows a bullish trajectory after a neutral start. The 2026 forecast lists min $1.10, avg $1.27, max $1.73 with ROI 0 and neutral sentiment. From 2028 onward the outlook turns bullish, with 2028 avg $1.60 and 2030 avg $1.94 (max $2.72, min $1.48) and ROI 52.8%.
By 2040 the avg price is projected at $4.57 (max $7.25) with ROI 259.8% and by 2050 the avg price reaches $8.27 (max $14.18) with ROI 551.1%, all while sentiment is bullish in those later years. The forecast also shows continued bullish sentiment through 2031–2035 and beyond, with higher maxes and increasingly larger ROIs, though these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $1.48, avg $1.94, max $2.72; ROI 52.8; sentiment BULLISH.
The forecast projects a bullish long-term path, with 2050 avg $8.27 and ROI 551.1%, and sentiment turning bullish from 2028 onward, though these are estimates and not guarantees.
Yes. The 2030 max is $2.72, and 2031 max is $3.14; 2032 max is $3.63, indicating potential for price above $2 in multiple years.
30-day range: low $1.10, high $1.47.
Current price $1.27; Market cap $958.97M; Rank 2564.
OPKO Health, Inc. Community Discussion
0Share your OPKO Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.